Skinvisible SKVI
OTC SKVI
$0.16 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Skinvisible (SKVI) EV to EBIT (2021 - 2022)

Updated

Skinvisible's (SKVI) EV to EBIT came in at 24.02 for Q3 2022, up 157.5% from 9.33 a year earlier and up 813.1% from the prior quarter.

Analysis

Skinvisible (SKVI) EV to EBIT (2021 - 2022) Analysis & Trends

For the trailing twelve months through Sep 30, 2022, EV to EBIT at Skinvisible was 14.65, up 103.9% year-over-year; for FY2021, it came in at 5.44.

  • According to Business Quant data, EV to EBIT for the three prior quarters was 2.63 (Q2 2022), 2.57 (Q1 2022) and 5.44 (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Skinvisible 864,614.86 855,592.86 5,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 24.02
Jun 30, 2022 2.63
Mar 31, 2022 2.57
Dec 31, 2021 5.44
Sep 30, 2021 9.33
API Access

Skinvisible EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=SKVI&period=max&api_key=YOUR_API_KEY